Earlier diagnosis of small intestine neuroendocrine tumours (SI-NETs) through transformation of the South Wales NET service.

Small intestine neuroendocrine tumours (SI-NETs) are often diagnosed late with a UK median of 3 years and high misdiagnosis rates. Previous studies, largely based on patient surveys, offer little data on improving diagnosis. In 2017, the South Wales NET service underwent a nationally commissioned, systematic transformation, aiming to improve diagnosis through the development of a gastroenterology and surgical referral network, and education of these specialities.

Revisiting the chondrichthyan egg capsules inventory from the Pennsylvanian (Carboniferous) of Belgium: new data and perspectives.

Records of chondrichthyan egg capsule morphotypes from the paralic deposits of the Belgian Coal Measures Group (Pennsylvanian; Bashkirian-Moscovian; Namurian B-Westphalian B according to the traditional subdivision) are presented and discussed. These include several species of the hybodontiform type Palaeoxyris as well as the putative holocephalian types Vetacapsula and Crookallia. Furthermore, the type specimens of Scapellites cottoni and S.

The erroneous chondrichthyan egg case assignments from the Devonian: implications for the knowledge on the evolution of the reproductive strategy within chondrichthyans.

Spiraxis interstrialis, and its junior synonym Fayolia mourloni, an uppermost Famennian (Upper Devonian) fossil first described as algae and subsequently interpreted as the oldest known chondrichthyan egg case, is reinvestigated based on the discovery of several additional specimens in Belgian collections. New data, in particular from micro-CT imaging, allow to refute S. interstrialis, and by extension also Spiraxis major (the type species of Spiraxis Newberry, non Adams) and Spiraxis randalli from the Famennian of New York and Pennsylvania, as chondrichthyan egg cases.

Interstitial lung disease and specialist palliative care access: a healthcare professionals survey.

Background: Fibrotic interstitial lung disease is an incurable disease with poor prognosis. We aimed to understand factors affecting decisions regarding referrals to specialist palliative care services and to address barriers and facilitators to referrals from healthcare professionals' perspectives.

Methods: A survey study of healthcare professionals, including respiratory physicians, interstitial lung disease nurse specialists, respiratory nurse specialists and palliative care physicians, was conducted using a questionnaire, entailing 17 questions.

Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate ( S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1 H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385).

HIF-2α, a member of the HIF family of transcription factors, is a key oncogenic driver in cancers such as clear cell renal cell carcinoma (ccRCC). A signature feature of these cancers is the overaccumulation of HIF-2α protein, often by inactivation of the E3 ligase VHL (von Hippel-Lindau). Herein we disclose our structure based drug design (SBDD) approach that culminated in the identification of PT2385, the first HIF-2α antagonist to enter clinical trials.